BioSpace News Archive

Drug Development

AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition

AstraZeneca recently reported positive interim data from clinical trials of two, and potentially a third, of its drugs for cancer.

June 27, 2019
·
3 min read
·
Mark Terry
Policy

Drug Prices, Purdue Pharma Are Points of Discussion in First Democratic Debate

During the first presidential debate of Democratic candidates vying for that party’s presidential nomination, it didn’t take long for the pharma industry to take center stage.

June 27, 2019
·
3 min read
·
Alex Keown
Drug Development

ImmunoGen Culls 220 Employees as it Focuses on New Phase III Trial

Following an operational review, ImmunoGen will prioritize continued development of mirvetuximab, as well as a select portfolio of three earlier-stage product candidates.

June 27, 2019
·
3 min read
·
Alex Keown
Business

Vaxess Technologies Closes Funding for Administering Vaccines Through a Bandage

Cambridge, Mass.-based Vaxess Technologies is inching closer to developing a bandage-like product that will be able to administer vaccines and other therapeutics through the skin.

June 27, 2019
·
2 min read
·
Alex Keown
Job Trends

BioSpace Movers and Shakers: Ambys, Decibel, Verona, and More

Biotech and pharma companies tap new members of executive leadership teams and boards.

June 27, 2019
·
6 min read
·
Alex Keown
Business

Polyphor appoints Frank Weber as new Chief Medical and Development Officer

Polyphor AG announced the appointment of Frank Weber, M.D., as Chief Medical and Development Officer, effective September 1, 2019.

June 27, 2019
·
3 min read
Business

Vivoryon Therapeutics AG enters myeloid immune checkpoint drug discovery, and collaborates with the University of Kiel to select cancer therapy candidates from its QPCTL inhibitor portfolio

Vivoryon Therapeutics AG, announced that they have entered into a research collaboration with University Medical Center Schleswig-Holstein, Campus Kiel, to discover and develop first-in-class therapeutics in cancer immunotherapy.

June 27, 2019
·
7 min read
Deals

Results of NOXXON Annual General Shareholders Meeting Held on June 25, 2019

NOXXON Pharma N.V. announced that the annual general shareholders meeting held on Tuesday, June 25, 2019 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands approved all voting items.

June 27, 2019
·
2 min read
Digital assistant shines with paints and coatings expertise

Speak up and be heard—never before have these words pertained to lab work quite the way they do now: thanks to COATINO™, the first digital laboratory assistant that Evonik is developing especially for the coatings industry.

June 27, 2019
·
5 min read
Genetown

CENTOGENE Launches PICOPglobal: Two Year Global Study on Colon- and Pancreas-Carcinoma

Driving personalized, immune-based therapy to target patients’ own immune responses

June 27, 2019
·
3 min read